The cluster is dominated by passive rebalancing with no active hedge fund or family office involvement. This provides no actionable directional signal. Monitor for filings from active managers or insiders for higher-conviction reads.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK AT ENTRY AT T+1- T+0 · Jun 11 $27.00entry
- T+1 · 5mo ago 0.00%α −0.54% · $27.00
- T+5 · due 5mo ago Pending
- T+20 · due 4mo ago Pending
- T+60 · due 2mo ago Pending
How similar events traded
Executive Summary
An institutional cluster for KalVista Pharmaceuticals shows 4 passive buyers (Wells Fargo, Schwab, Morgan Stanley, UBS) adding $9.4M in net new holdings and 1 passive seller (Fidelity) trimming $384K. However, all participants are mega-passive index funds, indicating routine rebalancing rather than a fundamental thesis. The net buying is modest relative to the $1.4B market cap, and historical 13F-based reads on KALV have underperformed.
Key Financial Metrics
Institutional Positions
Net institutional flow: $9.0M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Wells Fargo | ADD | +47.1% | $454.0K | $167.0K |
| Schwab | DOUBLED | +183.7% | $3.9M | $2.6M |
| Morgan Stanley | DOUBLED | +135.7% | $6.9M | $4.2M |
| UBS | ADD | +66.4% | $5.5M | $2.4M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Fidelity | TRIM | -30.8% | $1.5M | -$384.9K |
Key Facts
- 4 passive buyers added $9.4M net; 1 passive seller trimmed $384K.
- All participants are mega-passive/index funds, reducing signal strength.
- Net institutional buying represents ~0.6% of market cap.
Financial Impact
Total institutional accumulation of approximately $9.0M net, or ~0.6% of KALV's $1.4B market cap.
Risk Factors
- Passive flow is not fundamental conviction; positions may reverse next quarter.
- Low impact score reflects minimal new information.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-KALV-2025-Q3 |
Track record
12 reports on KALV
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +4.15% at T+5 after the Apr 17, 2026 report. 3 of 6 went positive at some point.
Filters
- Jun 22, 202621w ago 15-12G Bearish 7/10 No price data
- Jun 17, 202621w ago EFFECT Neutral 3/10 Entry $27.00 No price data
- Jun 11, 202622w ago 8-K Neutral 5/10 Entry $26.99 No price data
- Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Viewing Entry $27.00 No price data
- May 19, 202625w ago Insider Cluster Bearish 5/10 Entry $26.81 to $26.79 ▲ +0.07% +1.31% vs SPY
- May 19, 202625w ago Insider Cluster Neutral 2/10 Entry $26.81 to $26.79 ▼ −0.07% −1.31% vs SPY
- Apr 29, 202628w ago 8-K Bullish 8/10 Entry $26.67 to $26.71 ▲ +0.15% −2.96% vs SPY
- Apr 17, 202630w ago Insider Cluster Bearish 6/10 Entry $20.48 to $19.63 ▲ +4.15% +4.71% vs SPY
- Feb 23, 202638w ago Insider Cluster Bearish 6/10 Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
- Feb 23, 202638w ago Insider Cluster Bearish 7/10 Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers